Stock 688192 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Equities

688192

CNE1000055W8

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
37.15 CNY -0.67% Intraday chart for Dizal (Jiangsu) Pharmaceutical Co., Ltd. -12.09% -22.36%
Apr. 07 U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Dizal's Sunvozertinib for the First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations CI
Feb. 23 Dizal Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

f31471539ff0d0607a57505ae2.eVIp2cAFNmDiAhcQfKSCT2uK2k5Ghn2IwYO1FbQ98g4.DRtqrYh3AgSyLyF2N82wKQ_AgAwI8g-4j7rMW_FWoUgzJWKJt2YCC5FocA~00b3944d7c3d71faf5c88babf68d4f73

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
37.15 CNY
Average target price
52.16 CNY
Spread / Average Target
+40.39%
High Price Target
54 CNY
Spread / Highest target
+45.36%
Low Price Target
50.31 CNY
Spread / Lowest Target
+35.42%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 688192 Stock
  4. Consensus Dizal (Jiangsu) Pharmaceutical Co., Ltd.